- Home
- INO vs CBUS Comparison
INO vs CBUS Comparison
Compare INO & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- CBUS
- Stock Information
- Founded
- INO 1979
- CBUS 2010
- Country
- INO United States
- CBUS United States
- Employees
- INO N/A
- CBUS N/A
- Industry
- INO Medical/Dental Instruments
- CBUS Agricultural Chemicals
- Sector
- INO Health Care
- CBUS Industrials
- Exchange
- INO Nasdaq
- CBUS Nasdaq
- Market Cap
- INO 110.7M
- CBUS 127.1M
- IPO Year
- INO 1998
- CBUS 2017
- Fundamental
- Price
- INO $4.30
- CBUS $4.53
- Analyst Decision
- INO Buy
- CBUS Strong Buy
- Analyst Count
- INO 6
- CBUS 3
- Target Price
- INO $21.00
- CBUS $22.83
- AVG Volume (30 Days)
- INO 320.4K
- CBUS 148.0K
- Earning Date
- INO 11-14-2024
- CBUS 11-07-2024
- Dividend Yield
- INO N/A
- CBUS N/A
- EPS Growth
- INO N/A
- CBUS N/A
- EPS
- INO N/A
- CBUS N/A
- Revenue
- INO $203,413.00
- CBUS $4,152,999.00
- Revenue This Year
- INO N/A
- CBUS $36.93
- Revenue Next Year
- INO N/A
- CBUS $236.45
- P/E Ratio
- INO N/A
- CBUS N/A
- Revenue Growth
- INO N/A
- CBUS 449.34
- 52 Week Low
- INO $4.20
- CBUS $2.86
- 52 Week High
- INO $14.75
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- INO 23.84
- CBUS 51.52
- Support Level
- INO $5.25
- CBUS $4.30
- Resistance Level
- INO $5.60
- CBUS $6.10
- Average True Range (ATR)
- INO 0.27
- CBUS 0.52
- MACD
- INO -0.08
- CBUS 0.06
- Stochastic Oscillator
- INO 1.11
- CBUS 29.28
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.